Impact of CYP3A5 genetic polymorphism on pharmacokinetics of tacrolimus in healthy Japanese subjects

Similar Items

• Effects of CYP2D6 genotypes on age-related change of flecainide metabolism: involvement of CYP1A2-mediated metabolism
  od: Doki, Kosuke, i dr.
  Izdano: (2009)
• Influence of the CYP3A5 and MDR1 genetic polymorphisms on the pharmacokinetics of tacrolimus in healthy Korean subjects
  od: Choi, Ji H, i dr.
  Izdano: (2007)
• Pharmacokinetics and Safety of Defibrotide in Healthy Japanese Subjects
  od: Umemura, Kazuo, i dr.
  Izdano: (2016)
• Ataluren Pharmacokinetics in Healthy Japanese and Caucasian Subjects
  od: Kong, Ronald, i dr.
  Izdano: (2019)
• Comparative pharmacokinetics of maxacalcitol in healthy Taiwanese and Japanese subjects
  od: Liu, Ming-Che, i dr.
  Izdano: (2020)